Carmustine/Related Articles

Carmustine: Also known as BNCU for bis-chloronitrosourea, a nitrosourea-derived alkylating agent used in the therapy of lymphomas and gliomas; administered both intravenously and as a surgically implanted drug-releasing wafer ^[e]

This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.

Parent topics

• Antineoplastic agents [r]: Add brief definition or description

Subtopics

• Lymphoma [r]: A malignancy of the lymphoid immune cells. ^[e]
  • Diffuse large B-Cell lymphoma [r]: Add brief definition or description
  • Mycosis fungoides [r]: Add brief definition or description
  • Non-Hodgkin's lymphoma [r]: Any of a group of malignant tumors of lymphoid tissue that differ from Hodgkin's disease, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant Reed-Sternberg cells , a characteristic of Hodgkin's disease. ^[e]
• Glioma [r]: A central nervous system tumor, which may be benign or malignant, which arises from neuroglial cells ^[e]
  • Glioblastoma [r]: An aggressively invasive neoplasm of the central nervous system, primarily the brain; not curable but length of survival has improved somewhat in recent years ^[e]
  • Astrocytoma [r]: A glioma arising from astrocytes of the central nervous system; range from indolent to highly aggressive ^[e]
• Hematopoietic Stem Cell Transplantation [r]: Add brief definition or description